All of the September 9 enforcement letters citing DTC promotional content were issued at the center-level by the Center for Drug Evaluation and Research (CDER) or the Center for Biologics Evaluation ...

Please provide your email address to receive an email when new articles are posted on . The FDA said it will send letters to pharmaceutical companies asking for the removal of “misleading” drug ads.

On September 16, 2025, the U.S. Food and Drug Administration (FDA) released more than 60 warning letters sent to specific pharmaceutical manufacturers, alleging misbranding of a particular drug ...

This post was co-authored with Ms. Lily Johns, research coordinator at the University of Michigan. As discussed in a previous post, direct-to-consumer pharmaceutical advertising (DTCPA) is designed to ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

Direct-to-consumer drug ads have long blurred the line between patient empowerment and corporate persuasion, but the FDA is now moving to rein in misleading tactics on TV and social media. However, ...